• Recent News Releases

    November 16, 2014

    SCAI Statement on “Twelve or 30 Months of Dual Antiplatelet Therapy After Drug-Eluting Stents (DAPT),” Presented at AHA Scientific Sessions

    A new study presented today looks at the risks and benefits of continuing dual antiplatelet therapy beyond one year after placement of one or more drug-eluting stents as compared with aspirin therapy alone. The DAPT study’s authors conclude that, while continuing dual antiplatelet therapy with a thienopyridine (clopidogrel or prasugrel) in addition to aspirin after one year significantly reduced the risks of stent thrombosis and major adverse cardiovascular and cerebrovascular events, continuation was also associated with increased risk of bleeding.
    November 04, 2014

    SCAI Publishes Consensus Statement on Use of Left Ventriculography

    Once a common procedure, left ventriculography’s role in assessing heart disease has evolved considerably over the decades, leading to significant variations in use. A new expert consensus statement e-published today by the Society for Cardiovascular Angiography and Interventions (SCAI) recommends optimal uses for left ventriculography, with the goal of more standardized use of the test and improved quality of care for cardiac patients.
    October 01, 2014

    SCAI Expands AUC Calculator App to Support Clinical Decision Making for Diagnostic Catheterization and Imaging for Heart Failure

    New updates to the Society for Cardiovascular Angiography and Interventions’ (SCAI) highly regarded appropriate use criteria (AUC) calculator tool will help healthcare providers in making treatment decisions for patients who are candidates for diagnostic catheterization or imaging for heart failure. The updated tool – available online or through an iOS and Android app – is available for download today.
    September 29, 2014

    Societies Release First Appropriate Use Criteria for Pediatric Heart Disease

    The American College of Cardiology, along with eight partnering societies, released today the first appropriate use criteria for suspected heart disease in pediatric patients.
    September 14, 2014

    Study Finds Women Underrepresented in Interventional Cardiology Field

    Women make up just 4 percent of interventional cardiologists and they perform only 3 percent of all percutaneous coronary interventions (PCI), according to a new study conducted through the Society for Cardiovascular Angiography and Interventions (SCAI) Women in Innovations (WIN) initiative and presented today at the Transcatheter Cardiovascular Therapeutics (TCT) 2014 conference.
    September 12, 2014

    SCAI Names Lisa Olson Executive Director

    The Society for Cardiovascular Angiography and Interventions (SCAI) has named Lisa Olson, PhD, as its new executive director. Olson brings deep experience and expertise in the cardiovascular field and a vision for continuing to advance SCAI’s mission.
    August 19, 2014

    SCAI Statement on New Report Showing Heart Disease Deaths Dropped Significantly in Past Decade

    Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop in the rate of hospitalizations and deaths, according to a new study released today in the journal Circulation. The results are welcome news and emphasize the value of recent efforts by the cardiovascular community to support the delivery of timely, high-quality care to patients. Today’s news also underscores the need to remain committed to efforts to improve outcomes and access to appropriate heart disease care.
    August 19, 2014

    SCAI Publishes Expert Consensus Recommendations for Treatment of Renal Artery Stenosis

    Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations e-published in Catheterization and Cardiovascular Interventions today by the Society for Cardiovascular Angiography and Interventions (SCAI).
    July 18, 2014

    SCAI Publishes Expert Consensus Recommendations for Treating Below-the-Knee Peripheral Artery Disease (PAD)

    The incidence of obesity and diabetes is increasing, and with them the number of patients with peripheral artery disease (PAD) – or blockages in the arteries of the limbs. A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SCAI) will help physicians determine the best course of action for patients whose blockages reduce blood flow to their limbs, putting them at risk for gangrene and amputation. The third paper in the series, e-published today in Catheterization & Cardiovascular Interventions, outlines recommendations for treating infrapopliteal (IP), or “below-the-knee,” arterial disease.
    June 12, 2014

    Second in SCAI Appropriate Use PAD Series Provides Guidance on Treatment for Blocked Arteries Above the Knee

    New appropriate use expert consensus documents developed by the Society for Cardiovascular Angiography and Interventions (SCAI) provide guidance on treating the most common form of peripheral artery disease (PAD), namely blockages that affect arteries above the knee. The paper e-published today in Catheterization & Cardiovascular Interventions is the second in a series of PAD treatment recommendations released by SCAI. The series is aimed at helping physicians determine treatment options for the growing number of patients impacted by PAD.